Company Filing History:
1 out of 2 
1 out of 1 
1 out of 1 Years Active: 2025
Title: Innovations and Contributions of Inventor Zhenyan Li
Introduction
Zhenyan Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of tumor markers and RNA virus detection methods. With a total of 2 patents, his work has implications for diagnostics and therapeutic strategies.
Latest Patents
One of Zhenyan Li's latest patents is the "Methylation modification-based tumor marker STAMP-EP2." This invention provides a methylated tumor marker STAMP-EP2, which is hypermethylated in all tumor types and hypomethylated in corresponding normal tissue. The marker exhibits high sensitivity and specificity, and primers for detecting STAMP-EP2 can be utilized to prepare a tumor diagnostic kit.
Another significant patent is related to a "Target sequence of RNA virus and use thereof." This invention presents a target sequence of an RNA virus, which is a nucleic acid sequence fragment containing 20-40 bases with at least 95% similarity to the genome sequence of humans or related species. The patent also includes a primer composition for constructing the target sequence and biomaterials such as antisense RNA. This target sequence has important applications in the detection and diagnosis of RNA viruses, drug screening, and vaccine design.
Career Highlights
Zhenyan Li has worked with notable institutions, including the Shanghai Public Health Clinical Center and Shanghai Yizhe Biotechnology Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and patent development.
Collaborations
Throughout his career, Zhenyan Li has collaborated with esteemed colleagues such as Wenqiang Yu and Jianqing Xu. These collaborations have further enhanced his research and innovation capabilities.
Conclusion
Zhenyan Li's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in tumor diagnostics and RNA virus research.